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Summary
Background.— Conventional echocardiography is not a reliable method for characterizing tissue
patterns of intracardiac masses.
Aims.— To assess the ability of contrast echocardiography to characterize intracardiac masses.
Methods.— Thirty-one consecutive patients with an intracardiac mass were included in this
prospective study. All patients underwent conventional and contrast echocardiographic exam-
inations. Analysis of characteristics by contrast agent allowed classiﬁcation of intracardiac
masses as follows: complete lack of enhancement, suggesting thrombus; partial and/or incom-
plete enhancement, suggesting myxoma; complete enhancement, suggesting intracardiac
tumor. Tissue characteristics of intracardiac masses were also analyzed using at least one of
the following techniques: cardiac magnetic resonance, pathology of intracardiac mass and/or
mass resolved after anticoagulation during follow-up.
Results.— Using contrast echocardiography, an accurate diagnosis was made in all patients by an
experienced investigator and in all patients except one (97%), by a physician trainee (p = 0.31).
Among patients with a history of tumor, echocardiography allowed accurate diagnosis of the
nature of the mass in all patients; 50% of these patients presented with a secondary cardiac
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Conclusion.— L’échocardiographie de contraste pourrait être intéressante dans la caractérisa-
tion tissulaire des masses intracardiaques.
© 2009 Elsevier Masson SAS. Tous droits réservés.
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ackground
ntracardiac masses are found rarely [1]. Most are thrombi
fter myocardial infarction [2—5], although primary car-
iac tumors or metastatic involvement of the heart may
ccur [6]. Echocardiography is the technique of choice for
he detection of intracardiac masses in routine practice
7]. However, conventional echocardiography is not a reli-
ble method for characterizing the tissue patterns of these
asses. Cardiac magnetic resonance (CMR) can also be used
a
A
e
uo detect intracardiac masses and may offer clues that can
elp to determine tumor type [8—11], but CMR is not avail-
ble in most centres and its availability is restricted.
Contrast echocardiography using new contrast agents has
een proposed recently for the detection of thrombi and
o distinguish thrombi from tumors [12—14]. However, few
tudies have evaluated the accuracy of echocardiography
sing contrast agents. The aim of this study was to assess the
bility of contrast echocardiography to characterize intrac-
rdiac masses.
ethods
rom January 2004 until March 2008, we studied prospec-
ively 31 consecutive patients presenting with an intrac-N. Mansencal et al.
tumor and the others had a thrombus. Of the 14 patients with a thrombus located in the left
ventricle, 12 (86%) presented with left ventricular motion abnormalities using conventional
echocardiography, whereas wall motion abnormalities were observed in all 14 patients (100%)
using contrast agent. In these patients, 91 and 99% of left ventricular segments were well
visualized using conventional and contrast echocardiography, respectively (p < 0.0001).
Conclusions.— Contrast echocardiography may be useful for the tissue characterization of
intracardiac masses.
© 2009 Elsevier Masson SAS. All rights reserved.
Résumé
Contexte.— L’échocardiographie conventionnelle ne permet pas d’analyser les caractéristiques
tissulaires des masses intracardiaques.
Objectif.— Évaluer la capacité de l’échocardiographie de contraste à caractériser les différents
types de masses intracardiaques.
Méthode.— Trente et un patients avec masse intracardiaque ont été inclus consécutivement
dans cette étude prospective. Tous les patients ont bénéﬁcié d’une échocardiographie conven-
tionnelle et d’une échocardiographie de contraste. En échocardiographie de contraste, les
masses intracardiaques étaient classées de la fac¸on suivante : une absence complète de prise
de contraste était en faveur d’un thrombus, une prise partielle ou incomplète de contraste sug-
gérait un myxome et une prise complète de produit de contraste était en faveur d’une tumeur
intracardiaque. Les caractéristiques tissulaires des masses intracardiaques étaient également
analysées à partir d’au moins une des méthodes suivantes : imagerie par résonance magnétique,
les résultats de l’anatomopathologie et/ou la régression de la masse après anticoagulation.
Résultats.— Un diagnostic exact en échocardiographie de contraste était fait chez tous les
patients par un observateur expérimenté et chez tous les patients, sauf un (97 %) par un débu-
tant. Parmi les patients ayant des antécédents de cancer, l’échocardiographie permettait de
poser le bon diagnostic chez tous les patients : 50 % de ces patients avaient une tumeur sec-
ondaire et l’autre moitié un thrombus. Parmi les patients ayant un thrombus localisé dans le
ventricule gauche, 12/14 patients (86 %) présentaient un trouble de la cinétique segmentaire
détecté en échocardiographie conventionnelle alors qu’en utilisant du produit de contraste,
un trouble de la cinétique segmentaire était détecté chez tous les patients (100 %). Chez ces
patients, 91 et 99 % des segments ventriculaires gauches étaient analysables respectivement en
échocardiographie conventionnelle et en échocardiographie de contraste.rdiac mass detected by transthoracic echocardiography.
ll patients underwent a conventional echocardiographic
xamination followed by an echocardiographic examination
sing contrast agent.
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tContrast echocardiography and intracardiac masses
The tissue characteristics of the intracardiac masses
were also analyzed systematically using at least one of the
following methods: CMR, pathology of intracardiac mass
(sample of mass taken through femoral puncture or cardiac
surgery), left ventricular angiography and/or mass resolved
after anticoagulation and detected by serial echocardio-
graphic studies during follow-up. These methods were
considered to be our gold standards for determining the
tissue characteristics of an intracardiac mass. CMR (1.5 T
General electric medical systems, Milwaukee, WI, USA) was
performed using T1- and T2-weighted spin-echo images with
a multislice—multiphase technique. Gadolinium enhance-
ment T1-weighted spin-echo imaging was performed with
an intravenous injection of 0.2ml/kg Dotarem (Guerbet,
Aulnay, France). The image interpretation was performed
by two experienced radiologists, allowing determination
of the tissue characteristics of the intracardiac masses.
Masses resolved after anticoagulation were considered to
be thrombi.
Transthoracic echocardiography was performed using a
Siemens/Sequoia acuson system (Acuson, Mountain view,
CA, USA), equipped with multifrequency transducers and
capable of low energy (0.2 to 0.3mechanical index). Con-
ventional echocardiography was performed by two investi-
gators (N.M. and O.D.) according to guidelines [7,15,16].
All examinations were performed using second harmonic
imaging with a 1.9mechanical index. We analyzed intracar-
diac masses systematically using apical 4-, 3- and 2-chamber
views. We classiﬁed masses according to their location (left
ventricle [LV], right atrium [RA] or left atrium [LA]). At the
end of conventional transthoracic echocardiography, con-
trast echocardiography was performed systematically by
peripheral venous injection. Right and left heart opaciﬁca-
tion was obtained with Sonovue (Bracco Altana Inc., Milan,
Italy). We used a low mechanical index (0.2 to 0.3), avoiding
the destruction of microbubbles. After a 1.0ml intravenous
bolus of Sonovue (and, if necessary, a second 0.5ml intra-
venous bolus), and using CPS software (Siemens/Acuson,
Mountain view, CA, USA), we analyzed the characteristics of
the intracardiac mass. Once cardiac chambers were opaci-
ﬁed by contrast, an ultrasound impulse of high mechanical
index (1.9) was transmitted for at least four frames to
destroy microbubbles within the mass. In case of enhance-
ment of mass by contrast, this method allowed visualization
of the gradual contrast replenishment of the mass after this
impulse. Analysis of contrast characteristics allowed classi-
ﬁcation of intracardiac masses as follows:
• complete lack of enhancement, suggesting thrombus;
• partial and/or incomplete enhancement, suggesting myx-
oma;
• complete enhancement, suggesting intracardiac tumor
(Fig. 1).
No continuous infusion of contrast agent was performed
in accordance with limitations placed on its use in France.
All contrast echocardiographic studies were recorded anony-
mously and were interpreted by two independent observers
who were unaware of the clinical data and diagnoses
of the masses: an experienced investigator (observer 1)
and a physician trainee (< 15 contrast analyses; observer 2).
Among patients with left ventricular masses, the quality
of endocardial delineation in 17 left ventricular segments
p
p
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o
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as assessed systematically by observer 1 and was used
o determine the number of well-visualized left ventricu-
ar segments by second harmonic imaging and by contrast
gent.
tatistical analysis
tatistical analysis was performed using StatView version 4.5
Abacus Concepts, Inc, NC, USA). Continuous variables are
resented as means± SD and ranges. Continuous variables
ere compared using Fisher’s exact test or a paired t test.
nterobserver agreement in the interpretation of contrast
chocardiography was assessed. A p-value less than 0.05 was
onsidered to be signiﬁcant.
esults
opulation characteristics
he characteristics of the population are presented in
able 1. The mean age was 65± 16 years (range 29 to 93).
hirteen (42%) and ten (32%) patients had a history of
yocardial infarction and tumor, respectively. Thirty-one
atients with intracardiac mass were screened using con-
entional transthoracic echocardiography: 13masses were
resent in the RA, four in the LA and 14 in the LV. According
o the results of CMR, pathology and/or follow-up (res-
lution of thrombus by anticoagulation demonstrated on
erial echocardiographic studies), the ﬁnal diagnoses of the
asses were as follows: 21 thrombi, seven tumors and three
yxomas. The characteristics of the intracardiac masses are
resented in Table 1. Using conventional echocardiography,
misdiagnosis was made in seven patients (23%).
ontrast echocardiography
he intracardiac mass was visualized correctly by con-
rast agent in all patients (100%). No side-effects were
etected after Sonovue injection. The correct location
f the mass was detected by both observers using con-
rast echocardiography. The mean area of intracardiac
ass was 5.3± 4mm2 (range 0.7 to 15.3) with conven-
ional echocardiography and 5.3± 3.9mm2 (range 0.7 to
4.6) with contrast agent (p = 0.53). Using contrast echocar-
iography, observer 1 (experienced investigator) classiﬁed
he intracardiac masses as follows: complete lack of
nhancement (suggesting thrombus) in 21 patients; partial
nhancement (suggesting myxoma) in three patients; and
omplete enhancement (suggesting intracardiac tumor) in
even patients. All patients (100%) were classiﬁed correctly
y observer 1 using contrast echocardiography compared
ith the ﬁnal diagnosis of the mass determined by the gold
tandard method. Among patients with masses located in
he RA (n = 13), seven had no enhancement, whereas com-
lete enhancement was observed in six patients. Among
atients with masses located in the LA (n = 4), three had
artial enhancement whereas complete enhancement was
bserved in one patient. Among patients with masses
ocated in the LV (n = 14), all had no enhancement.
180 N. Mansencal et al.
Figure 1. Three examples of intracardiac mass in apical 4-chamber view according to the results of contrast echocardiography. A. Left
ventricular apical thrombus in a patient with a history of myocardial infarction. Contrast echocardiography revealed no enhancement of
t he RA
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Dhe mass. B. Secondary cardiac tumour (renal sarcoma) located in t
trial myxoma, with a partial enhancement of mass by contrast age
Observer 2 (physician trainee) classiﬁed the intracar-
iac masses as follows: complete lack of enhancement
n 21 patients, partial enhancement in two patients and
omplete enhancement in eight patients. An accurate diag-
osis was made by observer 2 in all patients except one
97%); in this single case of misdiagnosis, the intracardiac
ass was classiﬁed as a complete enhancement (intracar-
iac tumor), whereas the enhancement was actually partial
myxoma), as noted correctly by observer 1. Interobserver
greement in performing an accurate diagnosis using con-
rast echocardiography was 97%. Furthermore, the diagnosis
f the intracardiac masses improved signiﬁcantly in both
bservers using contrast echocardiography compared with
he ﬁrst suspected diagnosis performed by conventional
chocardiography according to previous history, clinical sta-
us and echocardiographic characteristics of mass (p = 0.005
or observer 1 and p = 0.02 for observer 2).
According to the interpretation of both observers, the
iagnoses of intracardiac masses using contrast echocardio-
raphy were accurate for all masses located in the RA and
T
d
t
p, with a complete enhancement of mass by contrast agent. C Left
V. Among the ten patients with a history of tumor, echocar-
iography allowed accurate diagnosis of the nature of the
ass in all patients; 50% of these patients presented with
secondary cardiac tumor and the others had a thrombus.
mong patients with thrombus located in the LV (n = 14),
2 (86%) presented with left ventricular motion abnormal-
ties using second harmonic imaging, whereas wall motion
bnormalities were observed in all 14 patients (100%) using
ontrast agent. In these patients, 252 left ventricular seg-
ents were analyzed: 230 (91%) and 249 (99%) segments
ere well visualized using second harmonic imaging and
ontrast echocardiography, respectively (p < 0.0001).
iscussionhe main ﬁnding of our study is that transthoracic echocar-
iography using contrast agent is an accurate method for
he tissue characterization of intracardiac mass in routine
ractice.
Contrast
echocardiography
and
intracardiac
m
asses
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Table 1 Characteristics of 31 patients with intracardiac mass.
No. Age
(yrs)/Sex
Location
of mass
Previous history Diagnosis of mass Modality of diagnosisa Contrast enhancement pattern
Observer 1b Observer 2b
1 29/F RA Melanoma Thrombus CMR & F/U None None
2 37/F RA — Angiosarcoma CMR & pathology Complete Complete
3 41/F LV Myocardial infarction Thrombus LV angiography & F/U None None
4 44/M LV Myocardial infarction Thrombus LV angiography & F/U None None
5 47/F RA — Thrombus CMR & F/U None None
6 47/M LV Myocardial infarction Thrombus CMR & F/U None None
7 49/F RA Sarcoma Thrombus CMR, pathology & F/U None None
8 55/M LV Myocardial infarction Thrombus Pathology None None
9 55/M LV Myocardial infarction Thrombus LV angiography & F/U None None
10 62/F RA Melanoma Secondary cardiac tumour CMR & pathology Complete Complete
11 62/F RA Renal carcinoma Secondary cardiac tumour CMR Complete Complete
12 62/M LV Myocardial infarction Thrombus LV angiography & F/U None None
13 64/F RA Lymphoma Secondary cardiac tumour CMR Complete Complete
14 64/M RA Leiomyosarcoma Thrombus CMR & F/U None None
15 64/F LA — Myxoma Pathology Partial Partial
16 67/M LV Myocardial infarction Thrombus LV angiography & F/U None None
17 68/F LA Indifferentiated adenocarcinoma Secondary cardiac tumour Pathology Complete Complete
18 69/F RA Melanoma Thrombus CMR & F/U None None
19 72/F LV Recurrent stroke Thrombus CMR & pathology None None
20 73/M LV Myocardial infarction Thrombus LV angiography & F/U None None
21 74/F RA — Thrombus CMR & F/U None None
22 74/M LV Myocardial infarction Thrombus Pathology None None
23 75/F LV Myocardial infarction Thrombus F/U None None
24 77/M LV Myocardial infarction Thrombus LV angiography & F/U None None
25 79/F RA Renal carcinoma Thrombus CMR & F/U None None
26 82/F RA — Sarcoma CMR & pathology Complete Complete
27 82/M LV Myocardial infarction Thrombus F/U None None
28 83/F LA — Myxoma Pathology Partial Complete
29 84/M LV Myocardial infarction Thrombus F/U None None
30 85/M RA Lung adenocarcinoma Secondary cardiac tumour CMR Complete Complete
31 93/M LA — Myxoma CMR Partial Partial
a F/U deﬁned as mass resolved after anticoagulation and detected by serial echocardiographic studies during F/U.
b Observers 1 and 2 were blinded to clinical and imaging data.
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Kirkpatrick et al. [12] demonstrated that pixel intensi-
ies in the intracardiac masses and in the adjacent section
f myocardium after injection of contrast agent allow the
ifferent types of intracardiac mass to be distinguished.
ontrast enhancement resulted in greater pixel intensity
etected by dedicated software and was suggestive of
umor, whereas decreased pixel intensity compared with the
yocardium was indicative of myxoma or thrombus. How-
ver, dedicated software for the analysis of pixel intensity is
ot widely available. Thus, in our study, we scored intracar-
iac masses visually as three groups: those with a complete
ack of enhancement by contrast agent, suggesting throm-
us; those with partial enhancement, suggesting myxoma;
nd those with complete enhancement, suggesting intrac-
rdiac tumor. This visual assessment may be performed
hatever the type of echocardiogram.
The different echocardiographic patterns can be
xplained by the characteristics of each mass. Most malig-
ant tumors have abnormal neovascularization, with high
lood supplies, which explains why these tumors present
n enhancement of mass by contrast agent. Myxomas
ave poor blood supplies, with partial enhancement by
ontrast agent. Finally, thrombi are avascular, with no
nhancement. In our study, a correct diagnosis was made by
n experienced investigator and a physician trainee in 100
nd 97% of cases, respectively, using contrast echocardiog-
aphy. Thus, regardless of the experience of the physician,
ontrast echocardiography is highly reproducible and gives
n accurate diagnosis with a simple and fast injection of
ontrast agent, which permits heart opaciﬁcation.
The introduction of second harmonic imaging has led to
he widespread use of transthoracic echocardiography for
he detection of intracardiac masses, except when exploring
he left atrial appendage [3,7]. Conventional echocardio-
raphy is useful for detecting left ventricular thrombi in
ost patients presenting with acute myocardial infarction
3]. However, we have demonstrated recently that con-
rast echocardiography is more reliable than conventional
chocardiography for the detection of these thrombi [13].
eft ventricular thrombi are usually associated with wall
otion abnormalities. In this study, the use of contrast agent
llowed us to detect all these wall motion abnormalities,
hereas conventional echocardiography was not efﬁcient in
heir detection in 14% of patients. This lack of accuracy with
onventional echocardiography is explained by the acquisi-
ion of a better endocardial border deﬁnition using contrast
gent. Most patients included in our study had thrombi, as
ould be expected in routine practice. The previous medi-
al history may sometimes be helpful in the interpretation
f echocardiography, particularly in patients with previous
yocardial infarction. Interestingly, in patients with a his-
ory of tumor, as was the case for ten patients in our study,
he accurate diagnosis of intracardiac mass is more difﬁcult.
ndeed, only 50% of these patients presented with an intrac-
rdiac tumor, whereas the others had a conﬁrmed thrombus.
lthough conventional echocardiography is unable to distin-
uish tissue characteristics, with the use of contrast agent,
t gave an accurate diagnosis of the masses in all these
atients.
In our study, all contrast echocardiographic studies were
erformed using speciﬁc imaging settings. Indeed, the use
f contrast agent needs a low mechanical index (0.2 toN. Mansencal et al.
.3), whereas conventional transthoracic echocardiography
eeds a high mechanical index. We performed contrast
chocardiography with CPS software that we use in routine
ractice in our echocardiographic laboratory. Most recent
chocardiograms have speciﬁc on-board software, allow-
ng automatic use of low mechanical index, with adequate
maging. However, in echocardiograms without dedicated
ontrast software, it is always possible to use contrast agent
ith a manual setting of mechanical index, and we believe
hat assessment of intracardiac mass by contrast agent may
e performed regardless of the software used, giving a reli-
ble diagnosis with this noninvasive technique.
The assessment of intracardiac masses by contrast
chocardiography requires speciﬁc contrast agent with right
nd left heart opaciﬁcation. A few months ago, the United
tates food and drug administration issued ‘‘black-box’’
arnings on use of perﬂutren-based ultrasound contrast
gents. However, a recent analysis of patients undergoing
linically-indicated echocardiography showed no increased
ortality risk associated with the use of contrast agent
17,18].
The main limitation of this study is the small number
f patients with cardiac tumors. Intracardiac tumors are a
ery rare ﬁnding and can be complex to assess. Further-
ore, perfusion imaging may be different according to the
ype of mass and this must be taken into account for their
nterpretation.
onclusion
his study demonstrates that two-dimensional echocar-
iography using contrast agent with right and left heart
paciﬁcation is an accurate method for the identiﬁcation
f intracardiac thrombi. Despite the small number and vari-
ty of cardiac tumors, contrast echocardiography may also
e useful for the tissue characterization of intracardiac
asses. Moreover, despite different clinical settings, con-
rast echocardiography is a reliable means of differentiating
etween tumor, myxoma and thrombus.
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